Industrial footprint
A key strength of Alcaliber is our Integrated Production model, which spans from cultivation to manufacturing of active pharmaceutical ingredients. This approach ensures superior quality control, consistency, and efficiency throughout all production stages.
INDUSTRIAL
Our key technologies and capabilities include:
-A 15,800m² industrial facility
-EU-GMP areas for intermediates and APIs
-Over 6,000m³ of purification reactors
-Treatment capacity of over 40 tons of granules per day
-More than 5 productive plants
-Organic solvent and CO2 extraction technologies
Our output includes NRMs, APIs, extracts, oils, and isolated products
AGRICULTURAL
Our agricultural areas, throughout Spain, benefit from the long-term expertise of our engineering and agricultural team, regularly cultivating 6,000-10,000 hectares in Spain with approximately 400 farmers and producing five commercial poppy straw varieties: Morphine, Codeine, Thebaine, Oripavine, and Noscapine.
Our key technologies and capabilities include:
-13.450 m2 warehouse
-FDA certificate
-10.000 t of straw granulates per year
-Output: Poppy seeds and poppy straw granulates
A strong and well recognized agricultural R&D team focused on crop management and to supply the best biomass to our manufacturing site
QUALITY
Our Quality Department is central to achieving excellence in manufacturing and ensuring customer satisfaction. We view quality as an ongoing process aimed at delivering safe and effective active ingredients, intermediates, and finished products.
Alcaliber’s comprehensive quality management system undergoes regular inspections by European (AEMPS) and international authorities (ANVISA, KDFA) and continuous audits by our most demanding clients. We comply with GMP Part II-ICH Q7 for Alkaloids and Cannabinoids and GMP Part I for high-quality cannabinoid-derived products, holding certification as a Pharmaceutical Laboratory.
Our stringent customer-oriented mindset and commitment to the highest quality standards ensure we consistently meet and exceed regulatory requirements and customer expectations
